Serum Bile Acid Metabolomics‐Based Machine Learning Model for Non‐Invasive Diagnosis of Gastric Cancer
Cancer Medicine · 2026
DOI: 10.1002/cam4.72346 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Nuo Yao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology & Hepatology, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, National Clinical R…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Metabolomics, Machine Learning, Biomarkers, Tumor. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Science and Technology Major Project.
Abstract (Originalsprache)
Background
Gastric cancer (GC) has posed a severe threat to human health. Metabolomics analysis has been applied in the context of multiple diseases, offering new perspectives for the development of non‐invasive detections.
Objective
We aimed to develop a diagnostic model for GC based on a serum bile acid (BA) panel.
Methods
A total of 632 participants were recruited for serum samples collection, and their clinical characteristics were recorded. Targeted BA profiling was conducted using ultra‐performance liquid chromatography–mass spectrometry (UPLC–MS). Participants from Xi'an were randomly allocated into a training cohort and an internal tuning cohort at a 7:3 ratio. The key BAs were identified through the two‐step selection method, and nine machine learning (ML) models were constructed and optimized. The optimal model was further evaluated externally using an independent validation cohort from Lanzhou.
Results
A panel of 10 serum BAs was confirmed for the construction of a diagnostic model. The XGBoost model exhibited the best performance on the tuning cohort, with an area under the receiver operating characteristic curve (AUROC) of 0.858. It also exhibited robust performance on the external validation cohort (AUROC = 0.816), significantly outperforming tumor markers (with the highest AUROC of CA72‐4 = 0.68). The developed model also demonstrated satisfactory predictive performance for patients with resectable stage GC (Stage I–II) (average precision [AP] = 0.75).
Conclusion
GC patients exhibit BA metabolic disorders. The XGBoost model based on a 10‐BA panel exhibited superior efficacy in GC detection, indicating its promising potential for clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology & Hepatology, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, National Clinical Research Center for Digestive Diseases, Xijing Hospital, The Fourth Mil…
- Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China.
- Department of Radiation Protective Medicine, Air Force Medical University, Xi'an, Shaanxi, China.
ORCID-Profile: Yongning Zhou, Junye Liu, Yongquan Shi
Förderung
- National Natural Science Foundation of China
- National Science and Technology Major Project
Zitieren
APA
Yao, N., Qu, X., Zheng, Y., Li, S., Fang, X., Lin, K., Zhao, X., Zhao, D., Zhou, Y., Liu, J., & Shi, Y. (2026). Serum Bile Acid Metabolomics‐Based Machine Learning Model for Non‐Invasive Diagnosis of Gastric Cancer. Cancer Medicine. https://doi.org/10.1002/cam4.72346
Vancouver
Yao N, Qu X, Zheng Y, Li S, Fang X, Lin K, et al. Serum Bile Acid Metabolomics‐Based Machine Learning Model for Non‐Invasive Diagnosis of Gastric Cancer. Cancer Medicine. 2026. doi:10.1002/cam4.72346
BibTeX
@article{Yao2026,
author = {Yao, Nuo and Qu, Xiaodong and Zheng, Ya and Li, Songbo and Fang, Xidong and Lin, Kexin and Zhao, Xingyu and Zhao, Danyang and Zhou, Yongning and Liu, Junye and Shi, Yongquan},
title = {Serum Bile Acid Metabolomics‐Based Machine Learning Model for Non‐Invasive Diagnosis of Gastric Cancer},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.72346}
}
EUVIMED